These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1540406)

  • 1. Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems.
    Rossi JJ; Elkins D; Zaia JA; Sullivan S
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):183-9. PubMed ID: 1540406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA enzymes (ribozymes) as antiviral therapeutic agents.
    Rossi JJ; Sarver N
    Trends Biotechnol; 1990 Jul; 8(7):179-83. PubMed ID: 1366622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the use of antisense, enzymatic RNA molecules (ribozymes) as therapeutic agents.
    Rossi JJ; Elkins D; Taylor N; Zaia J; Sullivan S; Deshler JO
    Antisense Res Dev; 1991; 1(3):285-8. PubMed ID: 1821650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR.
    Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
    Nucleic Acids Symp Ser; 1995; (34):125-6. PubMed ID: 8841584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gene expression with ribozymes.
    Marschall P; Thomson JB; Eckstein F
    Cell Mol Neurobiol; 1994 Oct; 14(5):523-38. PubMed ID: 7621511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological applications of hammerhead ribozymes as anti-viral molecules.
    Lustig B; Jeang KT
    Curr Med Chem; 2001 Aug; 8(10):1181-7. PubMed ID: 11472235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of RNA molecules containing self-releasing ribozymes targeted to lymphocytic choriomeningitis virus.
    Xing Z; Mahadeviah S; Whitton JL
    Antisense Res Dev; 1995; 5(3):203-12. PubMed ID: 8785476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribozymes: a new frontier in anti-HIV strategy.
    Sarver N
    Antisense Res Dev; 1991; 1(4):373-8. PubMed ID: 1821659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo.
    Taylor NR; Kaplan BE; Swiderski P; Li H; Rossi JJ
    Nucleic Acids Res; 1992 Sep; 20(17):4559-65. PubMed ID: 1408757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening effective target sites on mRNA: a ribozyme library approach.
    Unwalla HJ; Rossi JJ
    Methods Mol Biol; 2012; 848():329-36. PubMed ID: 22315078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.
    Rossi JJ; Sarver N
    Adv Exp Med Biol; 1992; 312():95-109. PubMed ID: 1514448
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes.
    Macejak DG; Jensen KL; Jamison SF; Domenico K; Roberts EC; Chaudhary N; von Carlowitz I; Bellon L; Tong MJ; Conrad A; Pavco PA; Blatt LM
    Hepatology; 2000 Mar; 31(3):769-76. PubMed ID: 10706571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of ribozymes to HIV infection.
    Rossi JJ
    Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribozymes as potential anti-HIV-1 therapeutic agents.
    Sarver N; Cantin EM; Chang PS; Zaia JA; Ladne PA; Stephens DA; Rossi JJ
    Science; 1990 Mar; 247(4947):1222-5. PubMed ID: 2107573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans-splicing ribozymes for targeted gene delivery.
    Köhler U; Ayre BG; Goodman HM; Haseloff J
    J Mol Biol; 1999 Feb; 285(5):1935-50. PubMed ID: 9925776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM; Pietras KM; Shin BJ; Misasi JN
    Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic applications of catalytic antisense RNAs (ribozymes).
    Rossi JJ
    Ciba Found Symp; 1997; 209():195-204; discussion 204-6. PubMed ID: 9383577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of adenoviral VAI small RNA as a carrier for cytoplasmic delivery of ribozymes.
    Prislei S; Buonomo SB; Michienzi A; Bozzoni I
    RNA; 1997 Jun; 3(6):677-87. PubMed ID: 9174101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
    Nosrati M; Li S; Bagheri S; Ginzinger D; Blackburn EH; Debs RJ; Kashani-Sabet M
    Clin Cancer Res; 2004 Aug; 10(15):4983-90. PubMed ID: 15297398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribozyme-mediated decrease in mumps virus nucleocapsid mRNA level and progeny in infected vero cells.
    Albuquerque-Silva J; Milican F; Bollen A; Houard S
    Antisense Nucleic Acid Drug Dev; 1999 Jun; 9(3):279-88. PubMed ID: 10435753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.